These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12756351)

  • 1. Determinants of successful synthetic hemodialysis vascular access graft placement.
    Rosas SE; Joffe M; Burns JE; Knauss J; Brayman K; Feldman HI
    J Vasc Surg; 2003 May; 37(5):1036-42. PubMed ID: 12756351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter evaluation of the bovine mesenteric vein bioprostheses for hemodialysis access in patients with an earlier failed prosthetic graft.
    Katzman HE; Glickman MH; Schild AF; Fujitani RM; Lawson JH
    J Am Coll Surg; 2005 Aug; 201(2):223-30. PubMed ID: 16038820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study.
    Gibson KD; Gillen DL; Caps MT; Kohler TR; Sherrard DJ; Stehman-Breen CO
    J Vasc Surg; 2001 Oct; 34(4):694-700. PubMed ID: 11668326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autogenous radial-cephalic or prosthetic brachial-antecubital forearm loop AVF in patients with compromised vessels? A randomized, multicenter study of the patency of primary hemodialysis access.
    Rooijens PP; Burgmans JP; Yo TI; Hop WC; de Smet AA; van den Dorpel MA; Fritschy WM; de Groot HG; Burger H; Tordoir JH
    J Vasc Surg; 2005 Sep; 42(3):481-6; discussions 487. PubMed ID: 16171591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of ACE inhibitors is associated with prolonged survival of arteriovenous grafts.
    Gradzki R; Dhingra RK; Port FK; Roys E; Weitzel WF; Messana JM
    Am J Kidney Dis; 2001 Dec; 38(6):1240-4. PubMed ID: 11728956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular access outcomes and medication use: a USRDS study.
    Yevzlin AS; Conley EL; Sanchez RJ; Young HN; Becker BN
    Semin Dial; 2006; 19(6):535-9. PubMed ID: 17150056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there impact of mortality prior hemodialysis therapy in peritoneal dialysis patients?
    Koc Y; Unsal A; Basturk T; Sakaci T; Ahbap-Dal E; Sinangil-Arar A; Kose-Budak S; Kayabasi H
    Nefrologia; 2012 May; 32(3):335-42. PubMed ID: 22508142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axillary loop grafts for hemodialysis access: midterm results from a single-center study.
    Jean-Baptiste E; Hassen-Khodja R; Haudebourg P; Declemy S; Batt M; Bouillanne PJ
    J Vasc Surg; 2008 Jan; 47(1):138-43. PubMed ID: 18178466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of preserved saphenous vein graft for the creation of access ports in hemodialyzed patients: report of 309 cases].
    Schneider M; Barrou B; Cluzel P; Hamani A; Bitker MO; Richard F
    Prog Urol; 2003 Sep; 13(4):585-91. PubMed ID: 14650287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin receptor blockers and antiplatelet agents are associated with improved primary patency after arteriovenous hemodialysis access placement.
    Jackson RS; Sidawy AN; Amdur RL; Khetarpal A; Macsata RA
    J Vasc Surg; 2011 Dec; 54(6):1706-12. PubMed ID: 21840155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Saran R; Dykstra DM; Wolfe RA; Gillespie B; Held PJ; Young EW;
    Am J Kidney Dis; 2002 Dec; 40(6):1255-63. PubMed ID: 12460045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospitalization risks related to vascular access type among incident US hemodialysis patients.
    Ng LJ; Chen F; Pisoni RL; Krishnan M; Mapes D; Keen M; Bradbury BD
    Nephrol Dial Transplant; 2011 Nov; 26(11):3659-66. PubMed ID: 21372255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Late nephrology referral influences on morbidity and mortality of hemodialysis patients. A provincial study].
    Peña JM; Logroño JM; Pernaute R; Laviades C; Virto R; Vicente de Vera C
    Nefrologia; 2006; 26(1):84-97. PubMed ID: 16649429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equivalent secondary patency rates of upper extremity Vectra Vascular Access Grafts and transposed brachial-basilic fistulas with aggressive access surveillance and endovascular treatment.
    Kakkos SK; Andrzejewski T; Haddad JA; Haddad GK; Reddy DJ; Nypaver TJ; Scully MM; Schmid DL
    J Vasc Surg; 2008 Feb; 47(2):407-14. PubMed ID: 18155874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex bypasses and fistulas for difficult hemodialysis access: a prospective, single-center experience.
    Chemla ES; Morsy M; Anderson L; Makanjuola D
    Semin Dial; 2006; 19(3):246-50. PubMed ID: 16689977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between gender and vascular access complications in hemodialysis patients.
    Astor BC; Coresh J; Powe NR; Eustace JA; Klag MJ
    Am J Kidney Dis; 2000 Dec; 36(6):1126-34. PubMed ID: 11096036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of the survival of permanent vascular access ports].
    Rodríguez JA; Ferrer E; Olmos A; Codina S; Borrellas J; Piera L
    Nefrologia; 2001; 21(3):260-73. PubMed ID: 11471307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single center experience in the use of polyurethaneurea arteriovenous grafts.
    Jefic D; Reddy PP; Flynn LM; Provenzano R
    Nephrol News Issues; 2005 Jul; 19(8):44-7. PubMed ID: 16104342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion of vascular access type among incident hemodialysis patients: description and association with mortality.
    Bradbury BD; Chen F; Furniss A; Pisoni RL; Keen M; Mapes D; Krishnan M
    Am J Kidney Dis; 2009 May; 53(5):804-14. PubMed ID: 19268411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of vascular access during daily and three times a week hemodialysis.
    Quintaliani G; Buoncristiani U; Fagugli R; Kuluiranu H; Ciao G; Rondini L; Lowenthal DT; Reboldi G
    Clin Nephrol; 2000 May; 53(5):372-7. PubMed ID: 11305810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.